Literature DB >> 29496685

An 88-year-old woman with flushing, alopecia and hirsutism and a Sertoli-Leydig cell tumour.

Zaina S Inam1, Abdul Hussain Azizi1, Soemiwati W Holland2.   

Abstract

Sertoli-Leydig cell tumour (SLCT) is a rare, androgen-secreting sex cord-stromal tumour of the ovary that usually occurs in young premenopausal women. The major clinical manifestations are virilisation and defeminisation. The following case describes an 88-year-old G1P1 woman, 40 years after menopause, who presented with flushing, hirsutism, voice changes and alopecia along with significantly elevated levels of testosterone. Postoperative report revealed a well-differentiated SLCT in the left ovary. This case is unique in that SLCT is a very rare cancer and even more so in an 88-year-old woman. Taking this case into consideration, it becomes reasonable to check androgen and oestrogen levels in postmenopausal women, not only in patients with signs of virilisation, but also in those with non-classical presentations, such as flushing or heat spells. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  endocrinology; gynecological cancer; obstetrics and gynaecology

Mesh:

Substances:

Year:  2018        PMID: 29496685      PMCID: PMC5847942          DOI: 10.1136/bcr-2017-222589

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Surgery for ovarian cancer: how to improve survival.

Authors:  Robert E Bristow; Jonathan S Berek
Journal:  Lancet       Date:  2006-05-13       Impact factor: 79.321

Review 2.  Sertoli-Leydig cell tumor presenting hyperestrogenism in a postmenopausal woman: a case report and review of the literature.

Authors:  Lili Guo; Xiang Yang; Huiting Zhu; Weimin Qiu; Xiaofei Shi; Bingqing Huang; Tao Duan
Journal:  Taiwan J Obstet Gynecol       Date:  2012-12       Impact factor: 1.705

3.  Cystic Sertoli-Leydig Cell Tumour in a Postmenopausal Woman with Absent Virilising Symptoms: A Diagnostic Challenge.

Authors:  Vidya Monappa; Saritha M Reddy; Ranjini Kudva; Muralidhar V Pai
Journal:  J Clin Diagn Res       Date:  2017-05-01

4.  A case of Sertoli-Leydig cell tumor in a postmenopausal woman.

Authors:  A Caringella; V Loizzi; L Resta; R Ferreri; G Loverro
Journal:  Int J Gynecol Cancer       Date:  2006 Jan-Feb       Impact factor: 3.437

5.  Steroid metabolism in an androblastoma (Sertoli-Leydig cell tumor): a histopathological and biochemical study.

Authors:  H E Stegner; B P Lisboa
Journal:  Int J Gynecol Pathol       Date:  1984       Impact factor: 2.762

6.  Sertoli-Leydig tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms.

Authors:  C Zaloudek; H J Norris
Journal:  Am J Surg Pathol       Date:  1984-06       Impact factor: 6.394

Review 7.  Sertoli-Leydig cell tumor with unique nail findings in a post-menopausal woman: a case report and literature review.

Authors:  Dalia Moghazy; Chakradhari Sharan; Malika Nair; Cassandra Rackauskas; Robert Burnette; Michael Diamond; Omar Al-Hendy; Ayman Al-Hendy
Journal:  J Ovarian Res       Date:  2014-08-28       Impact factor: 4.234

Review 8.  Sertoli - Leydig cell tumor with retiform areas and overgrowth of rhabdomyosarcomatous elements: case report and literature review.

Authors:  T Burnik Papler; S Frković Grazio; B Kobal
Journal:  J Ovarian Res       Date:  2016-07-30       Impact factor: 4.234

9.  Virilization in a Postmenopausal Female Due to Androgen Secreting Ovarian Dermoid Cyst.

Authors:  Murali Subbaiah; Gowri Dorairajan; Debasis Gochhait; G Vijayalakshmi
Journal:  J Midlife Health       Date:  2017 Apr-Jun

10.  A Case Report: Ovarian Sertoli-Leydig Cell Tumor With Hyperestrogenism and Endometrial Hyperplasia in a Postmenopausal Woman.

Authors:  Yoko Tsuzuki; Iwaho Kikuchi; Michio Nojima; Koyo Yoshida; Akane Hashizume; Shigeki Tomita
Journal:  Jpn Clin Med       Date:  2017-03-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.